Frequent or prolonged night wakings for your child? Contact Preferred Research Partners for an enrolling pediatric clinical study by emailing [email protected]

Is your child healthy and age 9-11? Consider our clinical research study for a Covid-19 and HPV Vaccine. ow.ly/R5VE50Nh9qX

Have you been diagnosed with either idiopathic or diabetic gastroparesis? You may qualify for our clinical study. Contact Preferred Research Partners at (501) 553-9987.

Struggling with CPAP? Now enrolling adults in for our Obstructive Sleep Apnea trial. More information at ow.ly/YLx750Nh9Wq

It is estimated that around 25% of North Americans and Europeans have gastroesophageal reflux disease (GERD). Participants between the ages of 12-17 years old may be eligible to take part in our clinical study. Contact Preferred Research Partners at (501) 553-9987 to learn more.

The challenges of teenagers with ADHD. childmind.org/article/adhd-i…

Now enrolling: The HUMMINGBIRD study is testing a protein-based COVID-19 study vaccine for children 6 months to 11 years of age. To learn more about participation requirements, click the link below. ow.ly/Gsy150Nhb2k

Women take your stand against CMV! Preferred Research Partners is now enrolling for a vaccine clinical trial for cytomegalovirus (CMV). For more information, email [email protected] or call (501) 553-9987.

Is anxiety interfering with your life? Call Preferred Research Partners to see if you qualify for our enrolling clinical study (501) 553-9987.

If your child is 9 to 11 years old and eligible for COVID-19 and HPV vaccines, they may qualify to join a clinical study ow.ly/fsTX50NheB6

Have you tried an anti-depressant medication, but it did not respond well? You may qualify for our clinical study. Call Preferred Research Partners at (501) 553-9987 to learn more.

Quality sleep is crucial for your child's health. Pediatric insomnia affects them emotionally, mentally, and physically, impacting the whole family. See if your child qualifies: preferredresearchpartners.com/studies/#!/stu… #PediatricInsomnia #ChildHealth #SleepStudy #Arkansas #LittleRock

📷 Happy 4th of July from Preferred Research Partners! 📷 Enjoy the festivities, stay safe, and thank you for being part of our journey toward groundbreaking healthcare solutions #4thOfJuly #IndependenceDay #ClinicalTrials #HealthcareInnovation #ThankYou #Arkansas #LittleRock

Is your child affected by ADHD? We're conducting a clinical trial to explore new treatments that could make a difference. Call to see if you qualify: 501-553-9987 #ADHD #ClinicalTrial #ResearchStudy #HealthcareInnovation #Arkansas

We’re enrolling children (ages 6-17) experiencing Migraine Headaches for a Clinical Research Study. The study is evaluating an investigational drug as a possible treatment for preventing Migraine Headaches in children. See if your child qualifies: preferredresearchpartners.com/studies/#!/stu…

🌟 Attention Parents: Is your child struggling with ADHD? Our clinical trial could offer new hope. Join us in exploring innovative treatments that aim to improve focus and quality of life. Find out if your child qualifies today by calling us at (501) 553-9987 #Arkansas

Child Migraine Headaches Study We are looking for children who suffer from migraines to take part in a study. No health insurance is required. Study related drug and care will be provided at no cost. Learn more here: preferredresearchpartners.com/studies/#!/stu…

Our adult migraine study is launching next month! If you suffer from chronic migraines and are looking for new treatment options, stay tuned for details on how you can get involved. Sign up here to get details about the study and to stay connected: preferredresearchpartners.com/contact-us/

New Study for Depression- Little Rock Learn about a new research study in Little Rock for individuals who struggle with depression despite their current medications. Study-related care provided at no cost. Call us at 501-553-9987 for more information

🎉 Exciting News, Fayetteville! 🎉 We’re thrilled to announce the opening of our new clinic! 🎈 We’re offering cutting-edge trials, including studies on Psilocybin for Depression, Preschooler ADHD, and Adult Bipolar Depression.